Geranylated nucleoside from Streptomyces
Y Igarashi et al
3
Scheme 1 Synthesis of 1. Reagents: (a) 2,2-dimethoxypropane, TsOH; (b) geranylbromide, NaH; (c) dil HCl.
solution was extracted with EtOAc. The organic layer was concentrated to give
16
12
8
1 (8.8 mg) as a colorless solid.
Simamycin (5-O0-geranyluridine, 1). Colorless needles; mp 95–96 °C; [α]D
24
+13 (c 0.10, CHCl3); UV λmax (log ε) 263 nm (3.90); IR (KBr) νmax 3377, 1694,
1664 cm− 1; For 1H and 13C NMR data, see Table 1. 15N NMR (CDCl3) δ 156.3
(N-1), 155.7 (N-3) (chemical shifts were indirectly determined from the
projection of 1H-15N HMBC spectrum); HR-FABMS [M+H]+ m/z 381.2027
(calcd for C19H30N2O6, 381.2025).
Bis-p-bromobenzoate of 1 (2)
4
To a solution of 1 (3.0 mg, 7.9 μmol) in dry CH2Cl2 (1.2 ml) and dry pyridine
(0.6 ml) were added N,N-dimethyl-4-aminopyridine (a trace amount) and p-
bromobenzoyl chloride (3.5 mg, 16 μmol) at 0 ~ 5 °C. After stirring for 20 h at
room temperature, the reaction mixture was diluted with ice water and
extracted with EtOAc. The organic layer was successively washed with sat.
CuSO4 solution, sat. NaHCO3 solution and brine, dried over anhydrous
Na2SO4 and concentrated under reduced pressure. The residue was purified by
silica gel column chromatography (hexane-EtOAc, 10:1~ 1:1) to give 2 (1.0 mg,
0
0
1.25 2.5
5
10 20 40 ROS
Simamycin (µM)
(ROS: 0.02 µM rosiglitazone)
1
Figure 4 Adipocyte differentiation induced by 1. A full color version of this
figure is available at The Journal of Antibiotics journal online.
17% yield) as a light yellow solid; H NMR (500 MHz, CDCl3) δ 8.16 (1H, s),
5.76 (1H, d, J = 8.2 Hz, H-5), 7.99 (1H, d, J = 8.2 Hz, H-6), 6.53 (1H, d,
J = 7.7 Hz, H-7), 5.62 (1H, dd, J = 7.7, 5.6 Hz, H-8), 5.73 (1H, m, H-9), 4.48
(1H, br.s, H-10), 3.81 (1H, dd, J = 9.4, 1.7 Hz, H-11), 3.72 (1H, dd, J = 9.4,
1.7 Hz, H-11), 4.18 (1H, dd, J = 11.6, 6.8 Hz, H-12), 4.13 (1H, dd, J = 11.6,
7.2 Hz, H-12), 5.37 (1H, t, J = 6.5 Hz, H-13), 2.31 (2H, m, H-15), 2.09 (2H, m,
H-16), 5.02 (1H, t, J = 6.6 Hz, H-17), 1.67 (3H, s, H-19), 1.73 (3H, s, H-20),
1.57 (3H, s, H-21), 7.84 (2H, d, J = 8.5 Hz), 7.46 (2H, d, J = 8.5 Hz), 7.73 (2H,
d, J =8.5 Hz), 7.58 (2H, d, J = 8.5 Hz); 13C NMR (125 MHz, CDCl3) δ 150.3
(C-2), 162.4 (C-4), 103.3 (C-5), 140.0 (C-6), 85.9 (C-7), 74.2 (C-8), 73.5 (C-9),
83.1 (C-10), 69.2 (C-11), 67.9 (C-12), 119.4 (C-13), 142.3 (C-14), 39.6 (C-15),
26.4 (C-16), 123.6 (C-17), 131.98 (C-18), 25.7 (C-19), 16.5 (C-20), 17.7
(C-21), 127.3, 127.7, 129.07, 129.13, 131.2, 131.3, 132.0, 132.1, 164.5, 164.8;
HR-FABMS [M+Na]+ m/z 767.0580 (calcd for C33H34N2O8Br2Na, 756.0579).
Microorganism
The actinomycete, Streptomyces sp. TP-A0872, was isolated from a soil sample
collected in Kochi, Japan. The isolated strain was identified as Streptomyces on
the basis of 99.9% similarity in the 16S rRNA gene sequence (1463 nucleotides;
DDBJ accession number LC192168) to Streptomyces xanthophaeus NRRL
B-5414T (accession number JOFT01000080).
Fermentation
Strain TP-A0872 cultured on a slant agar medium was inoculated into 500 ml
K-1 flasks, each containing 100 ml of the seed medium consisting of soluble
starch 1%, glucose 0.5%, NZ-case 0.3%, yeast extract (Kyokuto Pharmaceutical
Industrial, Co., Ltd, Tokyo, Japan) 0.2%, Tryptone (Difco Laboratories, Sparks,
MD, USA) 0.5%, K2HPO4 0.1%, MgSO4·7H2O 0.05% and CaCO3 0.3% (pH
7.0). The flasks were cultivated on a rotary shaker (200 r.p.m.) at 30 °C for
4 days. The seed culture (3 ml) was transferred into 500 ml K-1 flasks each
containing 100 ml of the production medium consisting of glucose 0.5%,
glycerol 2%, soluble starch 2%, Pharmamedia (Traders Protein) 1.5%, yeast
extract 0.3% and Diaion HP-20 (Mitsubishi Chemical Co., Yokohama, Japan)
1%. The pH of the medium was adjusted to 7.0 before sterilization. The
inoculated flasks were cultured on a rotary shaker (200 r.p.m.) at 30 °C for
7 days.
5-O-Geranyl-2,3-O-isopropylidene-1-uracil-β-D-ribofuranoside (4)
To a solution of uridine (700 mg, 2.87 mmol) in dry N,N-dimethylformamide
(70 ml) were added 2,2-dimethoxypropane (7 ml, 57 mmol) and p-toluene-
sulfonic acid monohydrate (70 mg, 0.37 mmol) at room temperature. After
stirring for 18 h, the reaction was quenched by adding saturated NaHCO3
solution to the reaction mixture until the pH became 7.0. The reaction mixture
was diluted with distilled water and loaded onto an HP-20 column and the
column was washed with distilled water. The column was then eluted with
MeOH and the eluent was concentrated under reduced pressure to give 2,3-O-
isopropylidene-1-uracil-β-D-ribofuranoside (3, 500 mg, 61% yield). Spectro-
scopic data were in good agreement with reported values.9
Extraction and isolation
The whole culture broth of strain TP-A0872 (3 l) was extracted with 1-butanol
(100 ml per flasks) on a rotary shaker (200 r.p.m.) for 1 h. The mixture was
centrifuged at 6000 r.p.m. for 10 min and the organic layer was separated from
the aqueous layer containing the mycelium. Evaporation of the solvent in vacuo
provided 5.23 g of extract, which was subjected to silica gel column
chromatography with a step gradient of CHCl3-MeOH (16:1, 8:1, 4:1, 2:1,
1:1 and 0:1 v/v). Concentration of fraction 2 (CHCl3-MeOH =8:1) provided
1.1 g of brown powders, which was further purified by HPLC separation with a
To a suspension of 3 (120 mg, 0.42 mmol) in a mixture of dry benzene
(1.45 ml) and dry 1,4-dioxane (0.45 ml) was added NaH (40% purity, 60 mg,
2.5 mmol) under argon atmosphere. The mixture was heated at 80~ 100 °C for
30 min with stirring. After cooling to the ambient temperature, geranyl
bromide (0.17 ml, 0.89 mmol) was added and the reaction mixture was heated
at 90~ 95 °C for 3 h. The reaction was quenched by adding water at 0 ~ 5 °C
and the mixture was extracted with EtOAc. The organic layer was dried over
anhydrous Na2SO4, filtered and concentrated in vacuo. The residue was applied
gradient of MeCN-0.15% KH2PO4 buffer (pH 3.5) (0–6 min: 40%; 6–20 min: to silica gel column chromatography (n-hexane:EtOAc = 16:1~ 1.1) to give
40–50%; 15 ml min−1). Compound 1 was eluted at 17.8 min. Fraction was 4 (39 mg, 22% yield): 1H NMR (500 MHz, CDCl3): δ 9.58 (1H, s), 7.68
pooled and concentrated under reduced pressure and the remaining aqueous (1H, d, J = 8.0 Hz), 5.95 (1H, d, J = 3.0 Hz), 5.67 (1H, d, J = 8.0 Hz), 5.29
The Journal of Antibiotics